Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised Studies-Reference-Cited by-同舟云学术

Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised Studies

Published:2023-11-29 Issue:12 Volume:37 Page:1081-1097
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Fuertig René,Goettel Markus,Herich Lena,Hoefler Josef,Wiebe Sabrina T.,Sharma Vikas

Funder

Boehringer Ingelheim

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40263-023-01041-4.pdf

Reference14 articles.

1. Tolentino JC, Schmidt SL. DSM-5 criteria and depression severity: implications for clinical practice. Front Psychiatry. 2018;9:450. https://doi.org/10.3389/fpsyt.2018.00450.

2. GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137–50. https://doi.org/10.1016/S2215-0366(21)00395-3.

3. Cowen PJ. Backing into the future: pharmacological approaches to the management of resistant depression. Psychol Med. 2017;47:2569–77. https://doi.org/10.1017/s003329171700068x.

4. Davies P, Ijaz S, Williams CJ, Kessler D, Lewis G, Wiles N. Pharmacological interventions for treatment-resistant depression in adults. Cochrane Database Syst Rev. 2019;12:10557. https://doi.org/10.1002/14651858.CD010557.pub2.

5. Dupuy JM, Ostacher MJ, Huffman J, Perlis RH, Nierenberg AA. A critical review of pharmacotherapy for major depressive disorder. Int J Neuropsychopharmacol. 2011;14:1417–31. https://doi.org/10.1017/s1461145711000083.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers;Clinical Drug Investigation;2024-04-24

2. Targeting TRP channels for pain relief: A review of current evidence from bench to bedside;Current Opinion in Pharmacology;2024-04

3. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males;CNS Drugs;2023-11-29